Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.

DC, Tong; S, Quinn; A, Nasis; C, Hiew; P, Roberts-Thomson; H, Adams; R, Sriamareswaran; NM, Htun; W, Wilson; D, Stub; Gaal W, van; L, Howes; N, Collins; A, Yong; R, Bhindi; R, Whitbourn; A, Lee; C, Hengel; K, Asrress; M, Freeman; J, Amerena; A, Wilson; J, Layland

doi:10.1161/circulationaha.120.050771

Public

Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.

Shared by NobleBlocks on Aug 29, 2020 • 12:00 AM UTC

Authors:

Tong DC

Quinn S

Nasis A

Abstract

Background Inflammation plays a crucial role in clinical manifestations and complications of acute coronary syndromes (ACS). Colchicine, a commonly used treatment for gout, has recently emerged as a novel therapeutic option in cardiovascular medicine owing to its anti-inflammatory properties. We sou...

Subject

Colchicine

Inflammation

acute coronary syndrome

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!